trava health semaglutide – Semaglutide and B12: Weight Loss
Description
& Auth.)
The weight loss signal in COPD patients is what makes the NIH paper resonate with the GLP-1 community
Coupled with cost-effectiveness concerns, the BCBSA data suggesting that many patients dont stay on their obesity medications long enough to experience clinically meaningful benefit present challenges for insurers making payment decisions regarding GLP-1s for weight loss.
The rates of major abdominal surgery were comparable between groups, and there was no sign of increased surgical risk
